Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Baxter
Accenture
Boehringer Ingelheim
Deloitte
Teva
McKinsey
Johnson and Johnson
Express Scripts

Generated: October 18, 2017

DrugPatentWatch Database Preview

OXYTETRACYCLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Oxytetracycline Hydrochloride, and what generic Oxytetracycline Hydrochloride alternatives are available?

Oxytetracycline Hydrochloride is a drug marketed by Purepac Pharm, Impax Labs, Proter, and Hikma Pharms. and is included in four NDAs.

The generic ingredient in OXYTETRACYCLINE HYDROCHLORIDE is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.

Summary for Tradename: OXYTETRACYCLINE HYDROCHLORIDE

US Patents:0
Applicants:4
NDAs:4
Bulk Api Vendors: see list79
Clinical Trials: see list2,285
Patent Applications: see list756
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYTETRACYCLINE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
OXYTETRACYCLINE HYDROCHLORIDE
oxytetracycline hydrochloride
CAPSULE;ORAL060634-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
OXYTETRACYCLINE HYDROCHLORIDE
oxytetracycline hydrochloride
CAPSULE;ORAL060770-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
OXYTETRACYCLINE HYDROCHLORIDE
oxytetracycline hydrochloride
CAPSULE;ORAL060760-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Proter
OXYTETRACYCLINE HYDROCHLORIDE
oxytetracycline hydrochloride
CAPSULE;ORAL060869-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Teva
McKesson
Fish and Richardson
Queensland Health
Mallinckrodt
Cipla
Moodys
Healthtrust
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot